Update on State Cannabis Laws and Trends for 2022


Wednesday, January 19, 2022


11:00 AM - 12:00 PM Pacific


As cannabis legalization continues to spread, employers need to track the ever-changing rules and regulations related to drug testing programs to balance employee safety at work with legal off-duty use. Employers in safety-sensitive industries and those with a multi-state footprint have an especially urgent need to balance safety and compliance, while retaining key employees.

This webinar will summarize state legalization trends for employers and their service providers. Attendees will learn about some of the impacts of changing state cannabis laws on workplace drug testing programs. In addition, attendees will learn about the benefits of the latest cannabis breath testing technology that can help employers maintain safety, retain employees, ensure compliance, and promote fairness.

Attend this 60-minute webinar to learn:

  • An overview of changes to state cannabis laws in 2021
  • A look ahead to potential changes in 2022
  • Cannabis windows of detection
  • The benefits of using a breath test for cannabis
  • Q&A





Partner and Co-Chair of the
Drug Testing Practice Group
Ogletree Deakins

Michael litigates cases and counsels large and small private for-profit and not-for-profit employers. Michael has expertise in drafting drug testing policies and in the complex scientific issues surrounding drug testing.




Partner and Co-Chair of the
Drug Testing Practice Group
Ogletree Deakins

Rayna is experienced representing and advising national, regional, and local clients on all aspects of employment law. She regularly advises employers on navigating multi-state drug testing issues and on recreational and medical marijuana laws.




Chief of Policy &
Strategic Initiatives
Hound Labs, Inc.

Doug has been working in public policy for 30+ years. He advocates for the shared goals of employers, employees, unions, legislators, law enforcement, community advocates, and cannabis policy groups.


The HOUND® MARIJUANA BREATHALYZER is intended to detect recent marijuana use. It does not measure whether, or how much, a person is impaired. It is intended solely for use in law enforcement, employment, and insurance settings. It should not be used for any medical or therapeutic purposes, or for any Federal drug testing programs, such as programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military.